The Fort Worth Press - Formerra to Supply Foster Medical Compounds in Europe

USD -
AED 3.672498
AFN 65.999835
ALL 79.100677
AMD 363.335236
ANG 1.789783
AOA 917.999918
ARS 1512.254297
AUD 1.389661
AWG 1.80125
AZN 1.698309
BAM 1.678344
BBD 2.011834
BDT 123.134088
BGN 1.696366
BHD 0.37664
BIF 2982.541201
BMD 1
BND 1.270558
BOB 11.561681
BRL 5.163798
BSD 0.99888
BTN 95.377196
BWP 13.383506
BYN 3.01243
BYR 19600
BZD 2.008916
CAD 1.38547
CDF 2274.999646
CHF 0.80413
CLF 0.023531
CLP 926.129792
CNY 6.719898
CNH 6.720965
COP 3159.36
CRC 453.872591
CUC 1
CUP 26.5
CVE 94.622484
CZK 20.73615
DJF 177.867597
DKK 6.41997
DOP 58.750107
DZD 133.131519
EGP 50.249801
ERN 15
ETB 163.156169
EUR 0.85887
FJD 2.1921
FKP 0.735368
GBP 0.736065
GEL 2.609921
GGP 0.735368
GHS 11.191824
GIP 0.735368
GMD 73.999896
GNF 8779.562695
GTQ 7.622832
GYD 208.973539
HKD 7.839985
HNL 26.859786
HRK 6.471301
HTG 130.678234
HUF 313.091012
IDR 17694
ILS 2.971798
IMP 0.735368
INR 95.451699
IQD 1310.5
IRR 1374599.999416
ISK 120.420069
JEP 0.735368
JMD 158.577871
JOD 0.709023
JPY 159.620499
KES 129.449894
KGS 87.449959
KHR 4045.999779
KMF 423.000204
KPW 900.000294
KRW 1372.000162
KWD 0.30878
KYD 0.832404
KZT 462.250064
LAK 22420.000319
LBP 89549.999984
LKR 328.168778
LRD 181.124989
LSL 15.990333
LTL 2.95274
LVL 0.60489
LYD 6.340257
MAD 9.254498
MDL 17.110542
MGA 4336.000017
MKD 52.796883
MMK 2099.772007
MNT 3598.777615
MOP 8.064704
MRU 40.119917
MUR 46.869432
MVR 15.449575
MWK 1736.99988
MXN 16.96208
MYR 4.026099
MZN 63.901418
NAD 15.986441
NGN 1341.349726
NIO 36.720237
NOK 9.31743
NPR 152.603825
NZD 1.68086
OMR 0.384495
PAB 0.998872
PEN 3.351027
PGK 4.43575
PHP 62.220103
PKR 277.601836
PLN 3.72095
PYG 5930.636185
QAR 3.64525
RON 4.516992
RSD 100.751036
RUB 85.529024
RWF 1469
SAR 3.756544
SBD 8.000251
SCR 13.756945
SDG 601.500781
SEK 9.52287
SGD 1.270499
SHP 0.740866
SLE 24.65038
SLL 20969.499227
SOS 570.842576
SRD 37.732016
STD 20697.981008
STN 21.4
SVC 8.740239
SYP 13001.999906
SZL 15.990526
THB 32.925963
TJS 9.214458
TMT 3.5
TND 2.896982
TOP 2.40776
TRY 48.245015
TTD 6.780228
TWD 31.599021
TZS 2647.502991
UAH 44.504096
UGX 3750.917134
UYU 40.152406
UZS 11809.999705
VES 790.677104
VND 26072.5
VUV 118.040776
WST 2.709953
XAF 562.910679
XAG 0.014218
XAU 0.000217
XCD 2.70255
XCG 1.800223
XDR 0.707052
XOF 562.905849
XPF 102.924984
YER 236.497294
ZAR 15.9813
ZMK 9001.19797
ZMW 19.003608
ZWL 321.999592
  • CMSC

    0.0350

    21.31

    +0.16%

  • RYCEF

    -0.1000

    20.75

    -0.48%

  • CMSD

    0.0200

    21.18

    +0.09%

  • JRI

    -0.0400

    12.4

    -0.32%

  • VOD

    -0.0600

    15.88

    -0.38%

  • RELX

    0.9600

    36.3

    +2.64%

  • BTI

    -1.1600

    56.28

    -2.06%

  • AZN

    -1.7500

    164.52

    -1.06%

  • RBGPF

    -0.4400

    70.69

    -0.62%

  • BP

    -0.1600

    42.34

    -0.38%

  • BCE

    -0.0900

    23.4

    -0.38%

  • BCC

    -1.1700

    78.77

    -1.49%

  • NGG

    -1.1000

    79.43

    -1.38%

  • GSK

    -1.1600

    50.27

    -2.31%

  • RIO

    0.0800

    104.78

    +0.08%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

B.Martinez--TFWP